Literature DB >> 2170285

Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation.

F Dallegri1, F Patrone, A Ballestrero, L Ottonello, F Ferrando, C Sacchetti.   

Abstract

The anti-inflammatory drug nimesulide was found to effectively reduce the availability of hypochlorous acid, the most potent chlorinated oxidant generated by the myeloperoxidase system of activated neutrophils. Such an effect was observed at concentrations achievable in vivo after the oral administration of the drug. Higher concentrations of nimesulide were also found to limit both the oxygen consumption and the superoxide anion/hydrogen peroxide production by neutrophils. Taken together, the results suggest that nimesulide is endowed with a high potential to efficiently control the harmful effects of oxidants produced by neutrophils at inflammatory tissue sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170285

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  7 in total

1.  Nimesulide. New clinical opportunities.

Authors:  S Tognella
Journal:  Drugs       Date:  1993       Impact factor: 9.546

2.  Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils.

Authors:  A J Verhoeven; A T Tool; T W Kuijpers; D Roos
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 3.  The effect of nimesulide on prostanoid formation.

Authors:  E Magni
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Antioxidant activity of nimesulide and its main metabolites.

Authors:  R M Facino; M Carini; G Aldini
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes.

Authors:  L Ottonello; P Dapino; G Pastorino; G Montagnani; F Gatti; G Guidi; F Dallegri
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of nimesulide.

Authors:  A Bernareggi
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

Review 7.  Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  R Davis; R N Brogden
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.